News | Womens Cardiovascular Health | March 31, 2016

American Heart Association Publishes Scientific Statement on Women and Heart Attacks

Statement illustrates the significant shift over time in treatment of acute myocardial infarction in women

American Heart Association, AHA, scientific statement, heart attacks, women, cardiovascular disease

March 31, 2016 — After a lengthy review of increasing medical evidence, the American Heart Association has published a scientific statement on the reduction in cardiovascular disease mortality in women. Per the study, “The dramatic decline in mortality rates for women is attributed partly to an increase in awareness, a greater focus on women and cardiovascular disease risk, and the increased application of evidence-based treatments for established coronary disease.”

“This is absolutely a good news story for women in terms of their health and cardiovascular disease,” said co-author Cindy L. Grines, M.D., vice president of Detroit Medical Center (DMC) Heart Hospital.

While often traditionally considered a disease of men, cardiovascular disease (CVD) is the leading cause of mortality for women in the United States. The study suggests that “although major progress has been made in reducing CVD mortality in women, medical research has historically neglected the health needs of women, apart from reproductive concerns.”

“It’s a longstanding misconception that cancer is the leading killer when it comes to women,” said Grines. “That’s actually second. According to the Centers for Disease Control, heart disease is the No. 1 killer of women in the U.S.”

But since 2000, the incidence of cardiovascular mortality in women has been on a decline, at a degree of thousands of lives saved. What’s changed?

“It’s a combination of advancements in treatment and education about cardiovascular disease among both patients and physicians,” said Grines. “We still have a long way to go in addressing the cardiovascular disease rate for women, but this data is a good indication that we are starting to do the right things, at the right time.”

Education about the differences between men and women in terms of cardiovascular disease and its risk factors has been, and continues to be, a key effort. “For decades, women were seen as ‘smaller men’ as far as heart disease was concerned, and needless to say, that’s incorrect,” said Grines. “There are clear differences in how women experience symptoms, in how the disease affects their body and in the effect risk factors have on their disease.

As an example, Grines cited modifiable risk factors such as depression, obesity and stress, which have very different rates of impact on cardiovascular disease risk – and all of them are higher when it comes to women. Patients and clinicians are learning to recognize symptoms in women that are different, such as shortness of breath, and pain in locations outside the chest, including arms, back, neck, jaw or stomach.

“The data in this new scientific statement is clear and compelling,” said Grines, who is also a professor of medicine at the Wayne State University School of Medicine. “We’ve known for some time that heart disease in women was different, and now we have support for more specific protocols for recognizing and treating it faster and better.”

For more information:

Related Content

Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Overlay Init